Cardiac Drugs 2 Flashcards

(102 cards)

1
Q

Sodium Bicarbonate Class

A

Systemic hydrogen ion buffer, alkalizing agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sodium Bicarbonate Mechanism of Action

A

Buffers metabolic acidosis and lactic acid buildup in the body caused by anaerobic metabolism secondary to severe hypoxia by reacting with hydrogen ions to form water and carbon dioxide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sodium Bicarbonate Indications

A

Metabolic acidosis during cardiac arrest, trycyclic antidepressant, aspirin, and PHENobarbital overdose, hyperkalemia, crush injuries.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sodium Bicarbonate Contraindications

A

Metabolic and respiratory alkalosis, hypokalemia, electrolyte imbalance due to severe vomiting or diarrhea.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sodium Bicarbonate Adverse reactions/side effects

A

Hypernatremia, metabolic alkalosis, tissue sloughing, cellulitis, mecrosis at injection site, seizures, fluid retention, hypokalemia, electrolyte imbalance, tetany, sodium retention, peripheral edema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sodium Bicarbonate Drug interactions

A

increases the effects of amphetamines. Decreases the effects of benzodiazapines, tricyclic antidepressants. May deactivate sympathomimetics(DOPamine, EPINEPHrine, norepinephrine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sodium Bicarbonate Adult Dosage and administration

A

1 mEq/kg slow IV, IO push, may repeat at 0.5 mEQ/kg every 10 minutes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sodium Bicarbonate Pediatric Dosage and administration

A

1 mEq/kg slow IV, IO push(dilute in small children to 4.2%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sodium Bicarbonate Duration of Action

A

onset: seconds
peak effect: 1 to 2 minutes
duration: 10 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sodium Bicarbonate Pregnancy safety category

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Sodium Bicarbonate Special Considerations

A

Repeat as needed in tricyclic antidepressant overdose until QRS narrows. Must be used in conjuction with effective ventilation and chest compressions in cardiac arrest. Avoid contact with other medications; may precipitate or inactivate them. Always flush IV line well before and after injecting. Use with caution in patients with heart failure and renal disease due to high sodium concentration. Monitor patient closely for signs and symptoms of fluid overload.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Furosemide (Lasix) class

A

loob diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Furosemide (Lasix) Mechanism of Action

A

Blocks the absorption of sodium and chloride at the distal and proximal tubules and the loop of Henle, causing increased urine output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Furosemide (Lasix) Indications.

A

Heart failure, pulmonary edema, hypertensive crisis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Furosemide (Lasix) Contraindications

A

hypovolemia, anuria, hypotension(relative contraindication), hypersensitivity, hepatic coma, suspected electrolyte imbalances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Furosemide (Lasix) Adverse reactions/ side effects

A

Dizziness, headache, ECG changes, weakness, orthostatic hypotension, dysrhythmias, nausea, vomiting, diarrhea, dry mouth, may exacerbate hypovolemia and hypokalemia, hyperglycemia(due to hemoconcentration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Furosemide (Lasix) Drug interactions

A

Lithium toxicity may be potentiated because of sodium depletion. Digitalis toxicity may be potentiated by potassium depletion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Furosemide (Lasix) Adult Dosage and administration

A

0.5 to 1mg/kg IV over 1 to 2 minutes. If no response, double the dose to 2 mg/kg slowly over 1 to 2 minutes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Furosemide (Lasix) Pediatric Dosage and Administration

A

1 mg/kg IV/IO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Furosemide (Lasix) Duration of action

A

onset: 5 minutes.
peak: 20-60 mins.
duration 4 to 6 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Furosemide (Lasix) Pregnancy safety

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Furosemide (Lasix) special considerations.

A

Should only be used during pregnancy if maternal benefit outweighs fetal risk. Ototoxicity, deafness and projectile vomiting can occur with rapid administration. Should be protected from light. Vasodilatory effects within 5 minutes; diuretic effects within 30 minutes. Expect 10 to 12 minutes. Expect to 10 12 mm Hg systolic and a 5 to 7 mm Hg diastolic drop in BP. Being phased out due to nephrotoxic side effects. Furosemide administration has decreased with the advent of CPAP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Labetalol (Normodyne, Trandate) Class

A

Selective alpha and nonselective beta adrenergic blocker, antihypertensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Labetalol (Normodyne, Trandate) Mechanism of action

A

BP reduction without reflex tachycardia; total peripheral resistance reduced without significant alteration in cardiac output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Labetalol (Normodyne, Trandate) Indications
Moderate to severe hypertension.
26
Labetalol (Normodyne, Trandate) Contraindications
Bronchial asthma, heart failure, cardiogenic shock, second and third degree heart block, bradycardia
27
Labetalol (Normodyne, Trandate) Adverse reactions/side effects
Fatigue, weakness, depression, headache, dizziness, bronchospasm, wheezing, dyspnea, bradycardia, heart failure, pulmonary edema, orthostatic hypotension, ventricular dysrhythmias, nausea, vomiting, diarrhea.
28
Labetalol (Normodyne, Trandate) Drug Interactions
Labetalol may block bronchodilator effects of beta adrenergic agonists. NTG may augment hypotensive effects.
29
Labetalol (Normodyne, Trandate) Adult Dosage and Administration
10 mg IV push over 1 to 2 minutes. May repeat or double every 10 minutes to a maximum dose of 150 mg. or infusion of 2 to 8 mg/min, titrated to supine BP.
30
Labetalol (Normodyne, Trandate) Pediatric Dosage and administration
Not recommended.
31
Labetalol (Normodyne, Trandate) Duration of action
onset: Less than 5 minutes peak: Variable duration: 3 to 6 hours.
32
Labetalol (Normodyne, Trandate) pregnancy safety category
C
33
Labetalol (Normodyne, Trandate) Special considerations
BP, pulse rate, and ECG should be monitored continuously. Observe for signs of heart failure, bradycardia, and bronchospasm. Should only be administered with patient in the supine position.
34
Metroprolol Tartrate (Lopressor) Class
Beta blocker, beta 1 selective
35
Metroprolol Tartrate (Lopressor) Mechanism of action
decreases heart rate, conduction velocity, myocardial contractility, and cardiac output. Used to control ventricular response in SVT(PSVT, AF, atrial flutter) Considered second line agent after adenosine, diltiazem, or digitalis derivative.
36
Metroprolol Tartrate (Lopressor) Indications
PSVT, atrial flutter, AF, reduces myocardial ischemia and damage in patients with AMI.
37
Metroprolol Tartrate (Lopressor) Contraindications
heart failure, second or third degree AV block, first degree heart block (if PR interval is equal to or greater than 0.24), sick sinus syndrome, cardiogenic shock, bradycardia.
38
Metroprolol Tartrate (Lopressor) Adverse reactions/ side effects
weakness, dizziness, depression, bronchospasm, wheezing, dyspnea, bradycardia, pulmonary edema, heart failure, AV blocks, hypotension, nausea, indigestion
39
Metroprolol Tartrate (Lopressor) Drug Interactions
Metoprolol may potentiate antihypertensive effects when given to patients taking calcium channel blockers or MAOIs. Catecholamine depleting drugs may potentiate hypotension
40
Metroprolol Tartrate (Lopressor) Adult Dosage and Administration
5 mg IV over 1 to 2 minutes. May repeat as needed every 5 minutes for a total of three doses.
41
Metroprolol Tartrate (Lopressor) Pediatric Dosage and Administration
Safety not established.
42
Metroprolol Tartrate (Lopressor) Duration of Action
onset 1 to 2 minutes peak: 5 to 10 minutes duration: 3 to 4 hours
43
Metroprolol Tartrate (Lopressor) Pregnancy safety Category
C
44
Metroprolol Tartrate (Lopressor) Special considerations
Contraindicated for use in breastfeeding women. Metoprolol must be given slow IV over 5 minutes. Concurrent IV administration with IV calcium channel blocker such as verapamil or diltiazem can cause severe hypotension. Metoprolol should be used with caution in patients with liver or renal dysfunction, hypotension, and COPD.
45
Nitroglycerin(Nitrostat, Nitro-Bid, Tridil) Class
Vasodilator
46
Nitroglycerin(Nitrostat, Nitro-Bid, Tridil) mechanism of action
Smooth muscle relaxant acting on vasculature, bronchial, uterine, intestinal smooth muscle. Dilation of arterioles and veins in the periphery. Reduces preload and afterload, decreasing workload of the heart, pulmonary edema.
47
Nitroglycerin(Nitrostat, Nitro-Bid, Tridil) Indictions
Acute angina pectoris, ischemic chest pain, hypertension, heart failure, pulmonary edema.
48
Nitroglycerin(Nitrostat, Nitro-Bid, Tridil)Contraindications
Hypotension, hypovolemia, intracranial bleeding or head injury, pericardial tamponade, severe bradycardia or tachycardia, RV infarction, previous administration in the last 24 hours: sildenafil (Viagra) or 48 hours: vardenafil (Levitra) or tadalafil (Cialis)
49
Nitroglycerin(Nitrostat, Nitro-Bid, Tridil) Adverse reactions/side effects
Headache, dizziness, weakness, reflex tachycardia, syncope, hypotension, nausea, vomiting, dry mouth, muscle twitching, diaphoresis.
50
Nitroglycerin(Nitrostat, Nitro-Bid, Tridil) Drug Interactions
Additive effects with other vasodilators. Incompatible with other drugs IV
51
Nitroglycerin(Nitrostat, Nitro-Bid, Tridil) Adult Dosage and Administration
0.4 mg SL; may repeat in 3 to 5 minutes to maximum of 3 doses. NTG IV infusion: Begin at 10 mcg/min; increase by 10 mcg/min every 3 to 5 minutes until desired effect. Maximum dosage of 200 mcg/min
52
Nitroglycerin(Nitrostat, Nitro-Bid, Tridil) Pediatric Dosage and Administration
Not recomended
53
Nitroglycerin(Nitrostat, Nitro-Bid, Tridil) Duration of Action
onset: 1 to 3 minutes peak: 5 to 10 minutes duration: SL:20 to 30 mintues, IV 1 to 10 minutes after discontinuation of infusion
54
Nitroglycerin(Nitrostat, Nitro-Bid, Tridil) Pregnancy safety Category
C
55
Nitroglycerin(Nitrostat, Nitro-Bid, Tridil) Special considerations
Has been used safely during pregnancy. Use caution with breastfeeding women and monitor infants for adverse effects. hypotension more common in older patients. If 12 lead ECG shows inferior wall infarct, rule out RV infarction prior to administering NTG. NTG decomposes when exposed to light or heat, must be kept in airtight containers. Must be administered only with an infusion pump direct from bottle with a vented IV set and non - PVC tubing. Active ingredient may have stinging effect when administered.
56
Nitropaste(Nitro-bid ointment) Adult Dosage and administration
Paste: apply a 1/2 to 3/4 inch (1 to 2 cm) line (15 to 30 mg), cover with wrap, and secure with tape. Maximum: 5 inch(12.5 cm) line(75 mg) per application. Transdermal: apply to intact skin (usually chest wall) in various doses.
57
Nitropaste Pediatric Dosage and administration
Not recommended
58
Nitropaste Special considerations
Wear gloves during application. Store paste in a cool place with tube tightly capped. Erratic absorption rates quite common.
59
Propranolol Hydrochloride(Inderal) class
Beta - adrenergic blocker
60
Propranolol Hydrochloride(Inderal) Mechanism of action
Nonselective Beta- adrenergic blocker that reduces chronotropic, inotropic, and vasokilator response to beta adrenergic stimulation.
61
Propranolol Hydrochloride(Inderal) Indications
Hypertension, angina pectoris, VT, VF refractory to lidocaine, selected SVT.
62
Propranolol Hydrochloride(Inderal) Contraindications
Sinus bradycardia(if no pacemaker present), second or third degree AV block(if no pacemaker present), bronchial asthma, sick sinus syndrome(if no pacemaker present), cardiogenic shock, heart failure, acute pulmonary edema
63
Propranolol Hydrochloride(Inderal) Adverse reactions/side effects
Weakness, depression, fatigue, anxiety, dizziness, bronchospasm, wheezing, hypotension, bradycardia, heart failure, AV blocks, nausea, vomiting, diarrhea, hypoglycemia, hyperglycemia
64
Propranolol Hydrochloride(Inderal) Drug interactions
Verapamil may worsen AV conduction abnormalities. Succinylcholine effects may be enhanced. Effects may be reversed by isoproterenol, norepinephrine, dopamine.
65
Propranolol Hydrochloride(Inderal) Adult Dosage and Administration
Dilute 1 to 3 mg in 10 to 30 mL of d5w. Administer slowly IV at rate of 1 mg/min. Maximum dose: 5mg
66
Propranolol Hydrochloride(Inderal) Pediatric Dosage and Administration
0.01 to 0.05 mg/kg per dose slow IV over 10 minutes. Maximum dose 3 mg
67
Propranolol Hydrochloride(Inderal) Duration of action
onset: 15 to 60 minutes peak: variable duration: 6 to 12 hours
68
Propranolol Hydrochloride(Inderal) Pregancy safety category
C
69
Propranolol Hydrochloride(Inderal) Special considerations
Use cautiosly in pregnant women due to potential and congenital anomalies. Closely monitor patient during administration. Use with caution in older patients. Atropine should be readily available.
70
Ceftriaxone (Rocephin) Class
Antibiotic
71
Ceftriaxone (Rocephin) Mechanism of Action
Inhibits bacterial cell wall synthesis
72
Ceftriaxone (Rocephin) Indications
Respiratory tract infections, skin infections, urinary tract infections, pelvic inflammatory disease, bacterial septicemia, bone and joint infections, and meningitis.
73
Ceftriaxone (Rocephin) Contraindications
Hypersensitivity
74
Ceftriaxone (Rocephin) Precautions
Calcium containing meds including OTC meds.
75
Ceftriaxone (Rocephin) Side Effects
Chest pain, chills, cough, fever, painful or difficult urination, shortness of breath, sore throat.
76
Ceftriaxone (Rocephin) Dosage
1 to 2 g IM or IV
77
Ceftriaxone (Rocephin) Route
IV, IM
78
Ceftriaxone (Rocephin) How Supplied
1g powder for reconstitution
79
Ceftriaxone (Rocephin) Pediatric Dosage
50 to 75mg/kg IM or IV
80
Ceftriaxone (Rocephin) Onset/Duration
<30 mins, 12 - 24 hours.
81
Tranexamic Acid (Cyklokapron, Lysteda) Class
Hemostatic agent, antifibrinolytic
82
Tranexamic Acid (Cyklokapron, Lysteda) Mechanism of action
Readuces plasminogen activation, mitigating conversion to plasmin
83
Tranexamic Acid (Cyklokapron, Lysteda) Indications
Blunt or penetrating trauma less than 3 hours from onset with hemodynamic compromise, bleeding
84
Tranexamic Acid (Cyklokapron, Lysteda) Contraindications
Hypersensitivity; MOI greater than 3 hours; subarachnoid hemorrhage; history of PE, DVT, or other thromboembolic disorder.
85
Tranexamic Acid (Cyklokapron, Lysteda) Adverse reactioin/side effects
Fatigue, headache, abdominal pain, anemia, DVT, PE, other thromboembolic disorder. Rapid infusion may cause hypotension.
86
Tranexamic Acid (Cyklokapron, Lysteda) Drug interations
Hormonal contraceptives, clotting factor complexes
87
Tranexamic Acid (Cyklokapron, Lysteda) Adult Dosage and administration
1 g IV infusion over 10 minutes.
88
Tranexamic Acid (Cyklokapron, Lysteda) Pediatric Dosage and administration
Not recommended
89
Tranexamic Acid (Cyklokapron, Lysteda) Duration of action.
onset: unknown peak: unknown duration: 7 to 8 hours
90
Tranexamic Acid (Cyklokapron, Lysteda) Pregnancy safety category
C
91
Tranexamic Acid (Cyklokapron, Lysteda) Special Considerations
Use in pregnant and breastfeeding women should be clearly indicated. Must be mixed into an infusion bag, typically 100 mL of NaCL
92
Vancomycin (Vancocin) Class
Antibiotic
93
Vancomycin (Vancocin) Mechanism of Action
Inhibits cell wall synthesis, cell membrane permeability, and RNA synthesis of gram positive bacteria
94
Vancomycin (Vancocin) Indications
Staphylococcal infections, clostridium difficile, endocarditis, meningitis, osteomyelitis, pneumonia, soft tissue infections.
95
Vancomycin (Vancocin) Contraindications
Hypersensitivity, allergy to corn or corn products, heart failure, renal disease or failure, ulcerative colitis.
96
Vancomycin (Vancocin) Adverse Reactions/side effects
Chills, dizziness, abdominal pain, nausea, vomiting, diarrhea, hypokalemia, hypotension, tinnitus, ototoxicity, nephrotoxicity/renal failure, urticaria, wheezing.
97
Vancomycin (Vancocin) Drug interactions
May enhance neuromuscular blockade with nondepolarizing muscle relaxants(eg pancuronium); Combined use with aminoglycosides may increase the risk of ototoxicity and nephrotoxicity.
98
Vancomycin (Vancocin) Adult Dosage and administration
7.5 mg/kg or 500 mg every 6 hours or 15 mg/kg or 1 g every 12 hours for 7 to 10 days IV infusion.
99
Vancomycin (Vancocin) Pediatric Dosage and Administration
40 mg/kg of body weight/24 hours equally divided and given every 6,8,12 hrs. for 7 to 10 days IV infusion
100
Vancomycin (Vancocin) Duration of Action
onset: Rapid peak effect: End of the infusion duration:12 to 24 hours.
101
Vancomycin (Vancocin) Pregnancy safety category
C
102
Vancomycin (Vancocin) Special considerations
Often administered to patients with penicillin allergies. Dose reduction required for patients with impaired renal function. Rapid infusion can cause histamine release resulting in "red man syndrome" that is characterized by flushing of the face, nech, upper body, arms, and or back. Symptoms usually resolve within 20 minutes but sometimes last for several hours. Stopping or slowing the infusion rate may reduce the severity of the reaction.